Visualitza per autor "Nishio, Makoto"
Ara mostrant els elements 1-2 d 2
-
Efficacy of Brigatinib in Patients With Advanced ALK-Positive NSCLC Who Progressed on Alectinib or Ceritinib: ALK in Lung Cancer Trial of brigAtinib-2 (ALTA-2)
Nishio, Makoto; Ahn, Myung-Ju; Barlesi, Fabrice; Felip Font, Enriqueta; Mok, Tony; Zhou, Caicun; Ou, Sai-Hong (Elsevier, 2022-12) -
Final Overall Survival and Other Efficacy and Safety Results From ASCEND-3: Phase II Study of Ceritinib in ALKi-Naive Patients With ALK-Rearranged NSCLC
Nishio, Makoto; Felip Font, Enriqueta; Orlov, Sergey; Park, Keunchil; Yu, Chong-Jen; Tsai, Chun-Ming (Elsevier, 2020-04)